A previous study demonstrated that a majority of COVID-19 patients had coagulation aberrations that manifested as high levels of D-dimers, fibrinogen and von Willebrand factor (vWF), prolonged prothrombin time and low platelet number (111). This evidence concerns the gene VWF and COVID-19.